Nonclassical congenital adrenal hyperplasia (NCAH) can lead to the production of excess male hormones. It is usually a mild condition and often doesn’t need to be treated. Nonclassical ...

A 29-year-old man was seen 2 years ago to transfer his care from pediatric to adult endocrinology. He was diagnosed at birth with classic congenital adrenal hyperplasia from 21-hydroxylase ...

To avoid in utero virilization of a female fetus, most, if not all, pregnant women at risk of congenital adrenal hyperplasia are currently treated with dexamethasone, as treatment must start at 6 ...

A prenatal pill for congenital adrenal hyperplasia to prevent ambiguous genitalia may reduce the chance that a female with the disorder will be gay. Drug may limit homosexuality - Los Angeles Times ...

Learn about a new drug for classic congenital adrenal hyperplasia (CAH). A top expert explains crinecerfont and its benefits, how it works, and its impact on CAH treatment.

Neurocrine's CRENESSITY Gains FDA Approval For Treating Congenital Adrenal Hyperplasia December 13, 2024 — 07:52 pm EST Written by RTTNews.com for RTTNews -> ...

SAN DIEGO — Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal hyperplasia succeeded in a late-stage trial, bringing the company a step closer to ...

Neurocrine Biosciences announced that its experimental drug for congenital adrenal hyperplasia succeeded in a late-stage trial of children and adolescents.

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced positive topline results from an open-label, Phase 2 congenital adrenal hyperplasia (CAH ...